The Substance Abuse journal Team wishes you, your teams, and families a very happy & safe Thanksgiving Holiday!
Eat lots and enjoy gobble day!
by AMERSA
The Substance Abuse journal Team wishes you, your teams, and families a very happy & safe Thanksgiving Holiday!
Eat lots and enjoy gobble day!
by AMERSA
The Authors’ Own Words:
We ask authors to describe their impressions regarding the implications of their accepted work, how their findings will change practice, and what is noteworthy about the work.
Constance Weisner, DrPH, MSW; Cynthia I. Campbell, PhD, MPH; Andrea Altschuler, PhD; Bobbi Jo H. Yarborough, PsyD; Gwen T. Lapham, PhD, MPH, MSW; Ingrid A. Binswanger, MD, MPH, MS; Rulin C. Hechter, MD, PhD; Brian K. Ahmedani, PhD, LMSW; Irina V. Haller, PhD, MS; Stacy A. Sterling, DrPH, MSW; Dennis McCarty, PhD; Derek D. Satre, PhD; & Andrea H. Kline-Simon, MS
Substance Abuse Vol. 40, Iss. 3, 2019
“Our goal was to identify opportunities to develop patient- and system-level interventions to facilitate initiation and engagement in AOD services, particularly among those who may be less likely to receive care. Initiation and engagement rates varied greatly, but they were low. Findings identified those over age 65, women, Hispanics, Black/African American and Asians (versus white) as less likely to initiate and those aged 30-49 and/or co-occurring conditions were more likely to engage. Primary care was the department with highest initiation rates, but those patients were less likely to engage in treatment. Focusing on these could help health systems develop interventions that facilitate AOD-IET.”
Follow us on twitter to stay up to date with SAj, upcoming publications, and more!
by AMERSA
The Authors’ Own Words:
We ask authors to describe their impressions regarding the implications of their accepted work, how their findings will change practice, and what is noteworthy about the work.
Amy M. Loree, PhD; Hsueh-Han Yeh, PhD; Derek D. Satre, PhD; Andrea H. Kline-Simon, MS; Bobbi Jo H. Yarborough, PsyD; Irina V. Haller, PhD, MS; Cynthia I. Campbell, PhD, MPH; Gwen T. Lapham, PhD, MPH, MSW; Rulin C. Hechter, MD, PhD; Ingrid A. Binswanger, MD, MPH, MS; Constance Weisner, DrPH, MSW; & Brian K. Ahmedani, PhD, LMSW
Substance Abuse Vol. 40, Iss. 3, 2019
“This paper examines the influence of psychiatric comorbidity on alcohol and other drug (AOD) treatment initiation and engagement among a large, diverse sample of health system patients with newly diagnosed AOD use disorders. Nearly two-thirds of patients with newly identified AOD use disorders also had a comorbid psychiatric disorder. Our findings indicated that identification of comorbid psychiatric disorders may increase initiation of AOD treatment but not engagement. We also found that the setting in which AOD use disorders are first identified among patients with comorbid psychiatric disorders may play a role in treatment initiation and engagement. Overall, these findings suggest that health care systems may need to consider adopting alternative approaches to improve identification and support of patients in need of treatment for both psychiatric and AOD use disorders.”
Follow us on twitter to stay up to date with SAj, upcoming publications, and more!
by AMERSA
The Authors’ Own Words:
We ask authors to describe their impressions regarding the implications of their accepted work, how their findings will change practice, and what is noteworthy about the work.
Rulin C. Hechter, MD, PhD; Michael A. Horberg, MD, MAS; Constance Weisner, DrPH, MSW; Cynthia I. Campbell, PhD, MPH; Richard Contreras, MS; Lie-Hong Chen, DrPH; Bobbi Jo H. Yarborough, PsyD; Gwen T. Lapham, PhD, MPH, MSW; Irina V. Haller, PhD, MS; Brian K. Ahmedani, PhD, LMSW; Ingrid A. Binswanger, MD, MPH, MS; Andrea H. Kline-Simon, MS; & Derek D. Satre, PhD
Substance Abuse Vol. 40, Iss. 3, 2019
“The findings of this study suggest people living with HIV and substance use disorders generally have greater number of comorbidities, including hepatitis C. Yet utilization of behavioral health services is low in this population. This is a clinically concerning pattern and requires more intensive support from the health systems and HIV specialists.“
Follow us on twitter to stay up to date with SAj, upcoming publications, and more!
by AMERSA
The Authors’ Own Words:
We ask authors to describe their impressions regarding the implications of their accepted work, how their findings will change practice, and what is noteworthy about the work.
Bonnie K. Lind, PhD; Dennis McCarty, PhD; Yifan Gu, MS; Robin Baker, PhD; & K. John McConnell, PhD
Substance Abuse Vol. 40, Iss. 3, 2019
“This is the first analysis that looks at predictors of SUD treatment in both adolescents and adults in a Medicaid population. We found substantive differences in predictors of treatment initiation and engagement between adults and adolescents, including in gender and race groups, urban vs. rural residence, and presence of a psychiatric diagnosis. These findings suggest that efforts to improve treatment and engagement generally may need to differentiate strategies for adult and adolescent populations. In particular, efforts that may be successful for improving these measures for adult populations may be ineffective for adolescent populations, and, depending on the strategies, could exacerbate existing racial and gender disparities.“
Follow us on twitter to stay up to date with SAj, upcoming publications, and more!